Competitive Advantages
- Customizes medical procedures with new adjunctive agents
- Administer additional agents to complement irradiation
Summary
Our researchers have devised an improved method and device for the delivery of additional therapeutic agents into cancerous tissue coordinated with the radiation treatment. This method is embodied in various forms of device order to tailor the procedure to meet the needs of the novel treatment strategies. The number of openings and the length of the region along the applicator can be varied depending on the tumor type and size being treated. Also, the size of the openings may vary to accommodate the therapeutic agent being used and with regards to previous or future treatment regimens. Additional therapeutic agents, including immunotherapy agents, dendritic cells, chemotherapy, antibodies, vaccines and others, can be incorporated into the treatment in order to maximize the therapeutic effect.
Illustrations of Example Devices for Delivering a Therapeutic Agent to a Subject
Desired Partnerships
- License
- Sponsored Research
- Co-Development